DiaMedica Therapeutics (DMAC) Interest & Investment Income (2024 - 2026)
DiaMedica Therapeutics (DMAC) reported Interest & Investment Income of $470000.0 for Q1 2026, up 5.86% on a YoY basis from $444000.0 in Q1 2025, and little changed quarter-over-quarter from $472000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest & Investment Income (2024 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Interest & Investment Income for 3 years, with the latest figure at $470000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 5.86% year-over-year to $470000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 20.39% YoY), and the FY2025 full-year result was $1.7 million, down 27.47% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $470000.0, roughly flat from $472000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $618000.0 in Q3 2024, with the low at $313000.0 in Q2 2025.
- Historically, Interest & Investment Income has averaged $493333.3 across 3 years, with a median of $472000.0 in 2025.
- Annual changes were most pronounced in 2025 — Interest & Investment Income tumbled 40.27% — and 2026, when it advanced 5.86%.
- DiaMedica Therapeutics' Interest & Investment Income stood at $543000.0 in 2024, then fell by 13.08% to $472000.0 in 2025, then dropped by 0.42% to $470000.0 in 2026.
- The last three Interest & Investment Income figures came in at $470000.0 (Q1 2026), $472000.0 (Q4 2025), and $440000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 470,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 470,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 440,000.00 |
| Jun 30, 2025 | 313,000.00 |
| Mar 31, 2025 | 444,000.00 |
| Dec 31, 2024 | 543,000.00 |
| Sep 30, 2024 | 618,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 616,000.00 |